Liberia vs Low income: Access to anti-retroviral drugs, female
Liberia
96.0%
in 2024
Low income
85.2%
in 2024
Liberia rank
14th
Low income rank
13th
Access to anti-retroviral drugs, female over time
- Liberia
- Low income
How they compare
Liberia currently reports 96.0% against 85.2% in Low income, a difference of 10.8%.
That makes Liberia's figure about 1.1 times Low income's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Low income ahead.
Liberia ranks 14th and Low income ranks 13th of 141 countries.
Low income has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Low income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 5.2% | 3.5% | Low income |
| 2010s | 27.4% | 46.8% | 19.4% | Low income |
| 2020s | 77.2% | 79.0% | 1.8% | Low income |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Liberia or Low income?
- Liberia, at 96.0% against 85.2% in Low income as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Liberia and Low income?
- 10.8%, with Liberia ahead.
- How many years of comparable data are there for Liberia and Low income?
- 25 years are reported by both, from 2000 to 2024.
- How do Liberia and Low income rank globally for access to anti-retroviral drugs, female?
- Liberia ranks 14th and Low income ranks 13th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.